Morgan Stanley Says China’s Reusable Rocket Progress Poses Long-Term Challenge to SpaceX 
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth 
SoftBank Corp Partners With Sierra to Expand AI Customer Support Across Japan 
Taiwan Mangoes Head to Europe as Premium Fruit Exports Expand 
ASML Raises 2026 Outlook as AI Chip Demand Lifts Q2 Earnings 
Genesis Minerals to Acquire Vault in A$5.6 Billion Deal After Regis Withdraws 
Alibaba Stock Jumps as China Approves Apple Intelligence Powered by Qwen AI 
Nvidia Tightens AI Chip Sales in Asia With Stricter Customer Approval Process 
Muji Owner Ryohin Keikaku Stock Soars After Raising Full-Year Earnings Forecast 
DBS Targets S$1 Trillion Wealth AUM by 2030 Amid Asia Wealth Boom 
Stripe, Advent Offer $53 Billion Deal to Acquire PayPal: Reuters 
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors 
Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business 
Rio Tinto Reports Strong Q2 Iron Ore Sales, Maintains 2026 Production Outlook 
Mastercard Explores Sale of Majority Stake in UK Payments Firm Vocalink: Report 
Arm Stock Falls After HSBC Downgrade, Citing Limited Near-Term AI Upside 
DeepSeek Eyes China IPO as AI Startup Seeks $71 Billion Valuation in New Funding Round 
NORCROSS, Ga., Jan. 14, 2016 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that it will hold a conference call with debt investors on Tuesday, February 2, 2016, at 2:00 p.m. ET to discuss its fiscal 2016 second quarter results.
Interested debt investors and analysts should contact Immucor Investor Relations at [email protected] or 770-441-2051 for details.
About Immucor
Founded in 1982, Immucor is a global leader in transfusion and transplantation diagnostics that facilitate patient-donor compatibility. Our mission is to ensure that patients in need of blood, organs or stem cells get the right match that is safe, accessible and affordable. With the right match, we can transform a life together. For more information on Immucor, please visit our website at www.immucor.com.
CONTACT: Michele Howard 770-441-2051
